Panacea Biotec Ltd
NSE: PANACEABIO BSE: 531349
₹347.55
(-1.75%)
Wed, 11 Mar 2026, 08:03 pm
Market Cap21.73B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KPanacea Biotec Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.42B | 8.37B | 8.41B | 7.88B | 9.00B | 11.43B | 6.98B | 5.73B | 4.97B | 6.75B | 6.26B | 5.33B | 5.86B | 4.53B | 5.38B | 6.18B | 6.60B | 4.58B | 5.54B | 4.94B |
| Gross profit | 2.01B | 3.26B | 2.11B | 2.14B | 2.44B | 3.79B | 377.60M | -219.50M | -110.90M | 1.23B | 1.79B | 1.41B | 1.20B | 31.02M | 1.34B | 1.44B | 792.76M | -316.73M | 446.53M | -64.47M |
| Operating expenses (excl. COGS) | -981.57M | -1.30B | 50.79M | -580.80M | -1.67B | -2.09B | -1.51B | -1.45B | -1.40B | -1.30B | -1.46B | -1.47B | -913.33M | -1.21B | -1.22B | -1.11B | -1.33B | -742.98M | -584.62M | -784.14M |
| Selling/general/admin expenses, total | -943.06M | -1.27B | — | — | -1.76B | -2.07B | -1.49B | -1.40B | -1.34B | -1.26B | -1.51B | -1.42B | -860.91M | -1.16B | -1.13B | -1.04B | -1.27B | -676.10M | -880.09M | -1.08B |
| Research & development | -237.89M | -395.11M | -410.51M | -500.92M | -753.06M | -753.10M | — | — | — | — | -452.80M | -425.23M | -144.60M | -157.73M | -205.13M | -125.62M | -105.09M | -139.13M | -368.70M | -376.82M |
| Selling/general/admin expenses, other | -705.17M | -875.98M | — | — | -1.01B | -1.32B | -1.49B | -1.40B | -1.34B | -1.26B | -1.06B | -992.42M | -716.31M | -997.50M | -928.90M | -919.37M | -1.16B | -536.97M | -511.39M | -704.08M |
| Other operating expenses, total | -38.51M | -29.59M | 50.79M | -580.80M | 85.00M | -20.10M | -23.30M | -44.20M | -57.30M | -37.20M | 45.80M | -49.51M | -52.42M | -53.36M | -90.49M | -66.20M | -61.11M | -66.88M | 295.47M | 296.76M |
| Operating income | 1.03B | 1.96B | 1.75B | 1.56B | 768.51M | 1.70B | -1.13B | -1.67B | -1.51B | -74.60M | 329.20M | -54.90M | 287.57M | -1.18B | 115.67M | 327.85M | -537.05M | -1.06B | -138.09M | -848.61M |
| Non-operating income, total | -67.71M | 130.99M | 96.16M | -2.46B | 359.20M | -156.10M | -1.42B | -863.40M | 403.50M | -919.50M | -518.50M | -463.88M | -924.92M | 1.66B | -1.83B | -1.77B | 15.03B | 1.19B | 152.86M | 769.13M |
| Interest expense, net of interest capitalized | -133.33M | -170.48M | -116.46M | -321.54M | -384.72M | -472.90M | -638.10M | -994.20M | -1.50B | -1.05B | -1.27B | -1.00B | -1.01B | -1.05B | -1.74B | -1.85B | -1.81B | -44.37M | -35.81M | -38.76M |
| Interest capitalized | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 67.90M | 301.47M | 212.62M | -309.30M | 743.92M | 319.20M | -529.20M | -36.80M | 155.00M | -73.80M | 305.30M | 461.92M | 80.86M | -75.64M | 62.60M | 124.90M | 16.85B | 1.25B | 201.40M | 797.34M |
| Non-operating interest income | 42.89M | 152.95M | 63.01M | 179.78M | 46.63M | 93.70M | 34.40M | 31.00M | 73.50M | 36.60M | 51.30M | 31.49M | 8.28M | 6.78M | 47.88M | 32.68M | 33.94M | 115.61M | 83.99M | 77.08M |
| Miscellaneous non-operating expense | 25.01M | 148.51M | 149.60M | -489.08M | 697.29M | 225.50M | -563.60M | -67.80M | 81.50M | -110.40M | 254.00M | 414.43M | 57.39M | -98.16M | 2.57M | 81.58M | 16.82B | 1.14B | 117.41M | 720.26M |
| Unusual income/expense | -2.27M | — | — | -1.82B | — | -2.40M | -252.20M | 167.60M | 1.75B | 199.60M | 446.20M | 77.22M | 0 | 2.79B | -153.97M | -42.63M | -15.74M | -21.12M | -12.73M | 10.55M |
| Pretax income | 960.09M | 2.09B | 1.84B | -896.06M | 1.13B | 1.54B | -2.55B | -2.53B | -1.11B | -994.10M | -189.30M | -518.78M | -637.35M | 486.15M | -1.72B | -1.44B | 14.49B | 128.05M | 14.77M | -79.48M |
| Taxes | -367.62M | -618.04M | -553.70M | 236.13M | -403.59M | -218.90M | 541.90M | 187.60M | -16.80M | -30.80M | -19.20M | 109.80M | -98.58M | -77.07M | -166.40M | -19.57M | -3.71B | -465.50M | -29.82M | -7.71M |
| Non-controlling/minority interest | 0 | 0 | 0 | -188.03K | 20.54K | 100.00K | — | 0 | 10.80M | 17.90M | 23.40M | 17.16M | 20.19M | 600.00K | 290.00K | -380.00K | -190.00K | 5.08M | 3.32M | 3.49M |
| After tax other income/expense | 0 | — | -832.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 592.47M | 1.48B | 1.34B | -654.81M | 817.18M | 1.45B | -2.06B | -2.34B | -1.12B | -1.07B | -182.90M | -391.82M | -715.74M | 409.68M | -1.88B | -1.46B | 10.78B | -332.37M | -11.73M | -83.70M |
| Net income | 592.47M | 1.48B | 1.34B | -654.81M | 817.18M | 1.45B | -2.06B | -2.34B | -1.12B | -1.07B | -182.90M | -544.84M | -739.78M | 377.27M | -1.94B | -1.48B | 10.78B | -332.37M | -11.73M | -83.70M |
| Dilution adjustment | 8.70M | 1 | 0 | -5.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 46.40M | 23.21M | 0 | 38.82K | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 554.76M | 1.45B | 1.34B | -659.96M | 817.18M | 1.45B | -2.06B | -2.34B | -1.12B | -1.07B | -182.90M | -544.84M | -739.78M | 377.27M | -1.94B | -1.48B | 10.78B | -332.37M | -11.73M | -83.70M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 1.22B | 2.34B | 2.22B | 2.28B | 1.27B | 2.29B | -362.40M | -807.30M | -802.10M | 597.80M | 1.06B | 624.61M | 860.39M | -637.55M | 547.86M | 783.79M | -99.28M | -668.48M | 226.70M | -503.44M |
| EBIT | 1.03B | 1.96B | 1.75B | 1.56B | 768.51M | 1.70B | -1.13B | -1.67B | -1.51B | -74.60M | 329.20M | -54.90M | 287.57M | -1.18B | 115.67M | 327.85M | -537.05M | -1.06B | -138.09M | -848.61M |
| Total operating expenses | -4.39B | -6.41B | -6.67B | -6.32B | -8.23B | -9.73B | -8.11B | -7.40B | -6.49B | -6.83B | -5.93B | -5.39B | -5.58B | -5.70B | -5.26B | -5.85B | -7.14B | -5.64B | -5.68B | -5.78B |
| Prepaid expenses | 470.44M | 1.13B | 1.44B | 1.67B | 1.63B | 1.92B | 289.90M | 25.00M | 44.50M | 30.40M | 36.60M | 34.88M | 47.73M | 32.23M | 56.48M | 52.87M | 53.49M | 52.20M | 60.63M | 71.08M |
| Deferred income, current | — | — | — | — | — | — | 13.40M | 8.40M | 300.90M | 113.00M | 177.70M | 123.05M | 104.15M | 117.34M | 147.94M | 647.75M | 1.72B | 766.13M | 775.13M | 765.90M |
| Capital and operating lease obligations | 605.14K | 605.14K | 3.49M | 163.12K | 0 | 16.40M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 296.55M | 466.37M | 639.01M | 820.30M | 850.03M | 837.70M | 766.20M | 648.60M | 942.80M | 895.90M | 845.30M | 110.94M | 92.57M | 1.47B | 1.34B | 1.20B | 1.04B | 1.00B | 992.69M | 818.93M |
| Deferred income, non-current | 0 | 0 | 0 | — | — | 0 | 0 | 23.60M | 17.30M | 7.00M | 3.40M | — | — | 1.49M | 3.03M | 0 | 431.33M | 321.39M | 218.46M | 108.52M |
| Minority interest | 0 | 0 | 0 | 28.97M | 48.34M | 64.00M | 66.00M | 73.50M | 54.80M | 34.20M | 10.80M | 105.40M | -29.49M | -30.09M | -30.38M | -30.00M | -29.81M | -34.89M | -38.21M | -41.70M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -138.32M | -94.00M | -76.87M | -81.15M | -38.82K | -15.60M | -45.90M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800